Cedars-Sinai is a non-profit medical center that provides primary and specialty care services. The company provides in-person care services and virtual consultations via Cedars-Sinai Connect. The company’s in-care facilities include a full suite of testing and treatment facilities, while its platform facilitates consultations for primary, urgent, and mental healthcare and second opinions on diagnoses from other healthcare providers. Cedars-Sinai additionally carries out research initiatives, functioning as a clinical research organization to operate clinical trials across various fields, including stem cell biology, immunology, and genetics.
As of April 2024, the company had over 40 in-person care facility locations, providing treatment for over 17 specialties, had a staff size of over 4,500 physicians and nurses, and had 1,500 research projects in progress.
Key customers and partnerships
In October 2023, Cedars-Sinai and K Health partnered to launch Cedars-Sinai’s virtual care platform, Cedars-Sinai Connect. Through the partnership, Cedars-Sinai was able to begin providing virtual care to patients in California for sick, chronic, and preventive care.
In January 2023, Cedars-Sinai partnered with women’s health startup Tia to expand access to primary and specialty care for women in Los Angeles. Through the partnership, Tia and Cedars-Sinai enabled access to physical, mental, and reproductive healthcare for more than 100,000 women.
In August 2021, Cedars-Sinai partnered with Alignment Healthcare to join Alignment’s partner network. Through the partnership, 1.5 million Medicare-eligible seniors of Alignment Healthcare gained access to Cedars-Sinai’s physicians.
Funding and financials
The company last raised funds in December 2023 when it received a USD 10,000 grant from the American Academy of Orthopaedic Surgeons (AAOS) as part of the 2024 AAOS IDEA Grant Program. The funding was awarded to Cedars-Sinai to support initiatives that focus on retaining and supporting a diverse workforce in orthopedic surgery in a private, remote setting or outside of academic institutions.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.